Inventor · disambiguated record
Maeva Dufies
Also filed as: DUFIES MAEVA
0 granted patents·7 pending applications·0 citations·filing 2017–2022
Files withCENTRE NAT RECH SCIENT3INST NAT SANTE RECH MED2INSERM INSTITUT NAT DE LA SANTE ET DR LA RECHERCH MEDICALE1UNIV AIX MARSEILLE1
Top patents by PatentIndex Score
7 records- 0151US2024316005A1Gene signatures for predicting survival time in patients suffering from renal cell carcinomaINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0249US2024199562A1Urea derivatives for treating uveal melanomaCENTRE NAT RECH SCIENT·Filed 2022·Application pending·0 cites
- 0342US2021380547A1Urea derivatives for treating and/or preventing cancerCENTRE NAT RECH SCIENT·Filed 2019·Application pending·0 cites
- 0439US2022137054A1New biomarkers and biotargets in renal cell carcinomaINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 0538US2020232989A1Methods and kits for predicting the sensitivity of a subject suffering of renal cancer to sunitinibUNIV AIX MARSEILLE·Filed 2018·Application pending·0 cites
- 0625US2022098674A1Methods and compositions for selecting a cancer treatment in a subject suffering from cancerINSERM INSTITUT NAT DE LA SANTE ET DR LA RECHERCH MEDICALE·Filed 2020·Application pending·0 cites
- 0724US2019195880A1Methods and kits for predicting the sensitivity of a subject suffering of renal cancer to cancer treatmentCENTRE NAT RECH SCIENT·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maeva Dufies files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →